In January 2022, Tracey Kassman, then 64 years previous, confronted the truth that her life could also be ending earlier than anticipated. She was identified with glioblastoma after docs uncovered a mind tumor. Glioblastoma has a mean life expectancy of 12-18 months.
“I had type of made peace with the concept that it is a terminal sickness, however I additionally realized that there was an entire lot of different stuff that I wished to do,” mentioned Tracey.
Tracey underwent radiation and chemotherapy at Roswell Park Complete Most cancers Middle. Then, to her shock, that April, she was offered with another choice.
“Dr. Chinazom Ibegbu, who I am keen on by the best way, mentioned, ‘I feel you’d be a superb candidate for this vaccine that we’re working trials on. Would you be taken with taking part?’ And I used to be like, ‘Let’s see … It’s a extremely dangerous prognosis if I don’t do something, so let’s simply do every little thing we probably can to attempt to guarantee that I’ve extra birthdays.”
And so, Tracey enrolled within the double-blind SurVaxM medical trial. That was three years in the past.
